Taiwan’s Academia Sinica has developed an Omicron-specific mRNA vaccine as a part of its world-leading research project. That was the word on Mo.
/ Staff writer, with CNAAcademia Sinica researchers have developed a series of next-generation COVID-19 vaccines that, according to early results, could be highly effective against the Omicron variant of SARS-CoV-2.
Academia Sinica researchers have developed a series of next-generation COVID-19 vaccines that, according to early results, could be highly effective against the Omicron variant of SARS-CoV-2.
Biomedical Translation Research Center researcher Tao Mi-hua (陶秘華) on Friday said that an Omicron-specific vaccine developed by the center produced 37 times as many neutralizing antibodies as other COVID-19 vaccines.
It was one of four vaccines created during the world-leading research project, together with Delta-specific, Omicron-Delta hybrid-specific and half-dose bivalent types.
While the initial findings showed the Omicron vaccine to be effective in tackling the highly transmissible variant, it was weaker against other strains of the disease.
The
Taipei, Feb. 11 (CNA) A team of researchers from Taiwan's Academia Sinica has developed a series of next-generation vaccines that early results show could be highly effective against the Omicron variant of COVID-19 as well as new mutations of the disease.